Public expenditure on TUBERCULOSIS in EL SALVADOR, during the fiscal year 2018
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of... key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.
more
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this... Global Plan include resources needed for implementing TB care and prevention and R&D into new tools. This Global Plan has already informed the Global Fund Investment Case and the 2022 G20 deliberations on TB. It will serve as a key document for inspiring and aligning global advocacy efforts, such as for the upcoming UNHLM on TB in 2023.
more
KNCV Tuberculosis Foundation - Your partner in the fight against TB
Accessed November 2017
Engage - TB
WHO/HTM/TB/2015.27
Chapter 8, Prison and Health, published
Guidance on Implending Publi-Private Mix Approaches
A survey of prevention, testing and treatment policies and practices
Workshop to share best practices and lessons learned in tuberculosis case finding and treatment in Western and Central Africa, 26 - 28 March 2018
Results of an innovative model launched in TB clinics in six regions
Accessed: 12.03.2020